跳至主要内容
临床试验/NCT02223429
NCT02223429已完成不适用

Biological Bases of Individual Variation in Paternal Nurturance

James K. Rilling, PhD2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
2
主要终点
Mean Percent Signal Change in the Anterior Cingulate Cortex

研究概览

简要总结

The overall goal of this project is to identify the genetic, hormonal, and neurobiological influences on paternal nurturing behavior and to determine if fathers' neural responses to infants can be modulated by neuropeptides known to play a role in parenting in experimental animal models.

The aim is to determine if pharmacological manipulation of central oxytocin (OT) and vasopressin (AVP) levels influences the neural response to viewing pictures of one's own infant or to hearing cry stimuli. In a double-blind procedure, fathers with 1-3 year old children will be scanned on two separate occasions; once under the influence of OT/AVP and once under the influence of placebo. Fathers will be randomized to either OT or AVP, and order of administration of drug and placebo will counterbalanced across subjects. Fathers will be scanned while viewing pictures of their own and an unknown child and while listening to unknown infant cry stimuli.

The investigators hypothesize:

  • OT will augment the ventral tegmental area (VTA), ventral striatum and medial orbitofrontal cortex (mOFC) response to viewing pictures of one's own child, and will augment the primary auditory cortex (AI) response of fathers to infant cries.
  • AVP will augment the lateral septum response to viewing own child pictures.

详细描述

30 fathers of children aged 1-3 will participate in two functional imaging sequence (fMRI) sessions, once under the influence of OT/AVP, and once under the influence of placebo. Fathers will be restricted to men who are living with their biological child and an adult partner (male or female) that they are in a committed relationship with. All fathers will receive two fMRI scans on two different occasions, separated by 2-10 days. 15 fathers will be randomized to intranasal OT, the other 15 will be randomized to intranasal AVP. Within each drug group, the order of administration of drug and placebo will counterbalanced across subjects, such that 15 will receive OT/AVP first, and 15 will receive OT/AVP second. During the fMRI scans, fathers will view pictures of their own and unknown children, as well as unknown adults. Afterwards, while still in the scanner, they will listen to infant cry and control stimuli. After exiting the scanner, fathers will again listen to the cry stimuli and will rate their emotional reaction to the cry stimuli on the following dimensions using a 7 point likert scale: irritated, sympathetic, alarmed, angry, upset, compassionate, distressed, annoyed, and tender.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • biological fathers of 1-3 year old infants who are currently cohabitating with the child's mother
  • normal or corrected-to-normal vision of 20/40

排除标准

  • current or past history of mental illness
  • active medical or neurological disorder
  • current or past history of alcohol or drug dependence
  • claustrophobic (at the discretion of the PI with subject consultation)
  • history of seizures or other neurological disorder
  • history of hypertension, cardiovascular disease, nephritis, diabetes or other endocrine diseases or malignancy
  • ferrous metal in any part of the body
  • history of asthma or migraine headaches (can be included at the discretion of the study physician or nurse practitioner if episodes are infrequent and no active problems at time of study, not medicated)
  • history of head trauma or psychiatric illness, as well as those who are receiving or have received over the past year, medication with known psychoactive effects (included at the discretion of the PI as these are exclusion criteria due to data quality concerns and not safety concerns; head trauma should be minimal enough deemed by the PI)

研究组 & 干预措施

OT + placebo

Experimental

The OT + placebo group will self-administer no more than 1 ml solution of oxytocin or placebo in each nostril; five (5) sprays per each nostril, for a total of ten (10) sprays. The order of administration of drug and placebo will counterbalanced across subjects, such that half will receive OT first, and half will receive OT second.

干预措施: Oxytocin (Drug)

OT + placebo

Experimental

The OT + placebo group will self-administer no more than 1 ml solution of oxytocin or placebo in each nostril; five (5) sprays per each nostril, for a total of ten (10) sprays. The order of administration of drug and placebo will counterbalanced across subjects, such that half will receive OT first, and half will receive OT second.

干预措施: Placebo (Drug)

AVP + placebo

Experimental

The AVP + placebo group will self-administer no more than 1 ml solution of vasopressin or placebo in each nostril; five (5) sprays per each nostril, for a total of ten (10) sprays. The order of administration of drug and placebo will counterbalanced across subjects, such that half will receive AVP first, and half will receive AVP second.

干预措施: Vasopressin (Drug)

AVP + placebo

Experimental

The AVP + placebo group will self-administer no more than 1 ml solution of vasopressin or placebo in each nostril; five (5) sprays per each nostril, for a total of ten (10) sprays. The order of administration of drug and placebo will counterbalanced across subjects, such that half will receive AVP first, and half will receive AVP second.

干预措施: Placebo (Drug)

结局指标

主要结局

Mean Percent Signal Change in the Anterior Cingulate Cortex

时间窗: Baseline, Visit 2 (Up to 10 days)

The effect of the drug will be assessed by determining changes in brain activation to own child pictures versus adult pictures (O-A) between OT treatment and placebo treatments (OT-PL) from functional magnetic resonance imaging (fMRI).

Mean Percent Signal Change in Caudate Nucleus

时间窗: Baseline, Visit 2 (Up to 10 days)

The effect of the drug will be assessed by determining changes in brain activation to own child pictures versus adult pictures (O-A) between OT treatment and placebo treatments (OT-PL) from functional magnetic resonance imaging (fMRI).

Mean Percent Signal Change in Ventral Tegmental Area (VTA)

时间窗: Baseline, Visit 2 (Up to 10 days)

The effect of the drug will be assessed by determining changes in brain activation to own child pictures versus adult pictures (O-A) between OT treatment and placebo treatments (OT-PL) from functional magnetic resonance imaging (fMRI). Changes will be assessed in the OT group only per protocol.

Mean Percent Signal Change in Right Ventral Striatum

时间窗: Baseline, Visit 2 (Up to 10 days)

The effect of the drug will be assessed by determining changes in brain activation to own child pictures versus adult pictures (O-A) between OT treatment and placebo treatments (OT-PL) from functional magnetic resonance imaging (fMRI). Changes will be assessed in the OT group only per protocol.

Mean Percent Signal Change in the Visual Cortex

时间窗: Baseline, Visit 2 (Up to 10 days)

The effect of the drug will be assessed by determining changes in brain activation to own child pictures versus adult pictures (O-A) between OT treatment and placebo treatments (OT-PL) from functional magnetic resonance imaging (fMRI).

Mean Percent Signal Change in Right Medial Orbitofrontal Cortex

时间窗: Baseline, Visit 2 (Up to 10 days)

The effect of the drug will be assessed by determining changes in brain activation to own child pictures versus adult pictures (O-A) between OT treatment and placebo treatments (OT-PL) from functional magnetic resonance imaging (fMRI). Changes will be assessed in the OT group only per protocol.

次要结局

  • Difference in Cry Rating Scores Between OT and Placebo(Baseline, Visit 2 (Up to 10 days))
  • Change in Plasma Levels of Vasopressin (AVP)(Baseline, Visit 2 (Up to 10 days))
  • Change in Plasma Levels of Oxytocin (OT)(Baseline, Visit 2 (Up to 10 days))
  • Mean Percent Signal Change in Primary Auditory Cortex(Baseline, Visit 2 (Up to 10 days))
  • Difference in Cry Rating Scores Between AVP and Placebo(Baseline, Visit 2 (Up to 10 days))
  • Mean Percent Signal Change in Right Lateral Septum(Baseline, Visit 2 (Up to 10 days))

研究者

发起方
James K. Rilling, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

James K. Rilling, PhD

Associate Professor

Emory University

研究点 (2)

Loading locations...

相似试验

Neurobiological Bases of Paternal Nurturance | 临床试验